» Articles » PMID: 4027966

Relationships of Prostaglandin E and Natural Killer Sensitivity to Metastatic Potential in Murine Mammary Adenocarcinomas

Overview
Journal Cancer Res
Specialty Oncology
Date 1985 Oct 1
PMID 4027966
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The levels of two prostaglandins (prostaglandins E and F) have been determined in a series of murine mammary lesions ranging from preneoplastic, hyperplastic alveolar nodules to highly metastatic adenocarcinomas. A highly positive correlation was seen between high levels of prostaglandin E and high tumorigenicity and metastatic potential. In addition, spontaneous metastasis of two highly metastatic tumors was partially inhibited by p.o. administration of indomethacin from the time of s.c. tumor transplantation until removal of the primary tumor at a limited size. Further, mammary tumor cells of differing metastatic potential were susceptible to polyinosinic-polycytidylic acid activated spleen lymphocytes in vitro. Cells of metastatic tumor lines (410.4 and 66) were more resistant to killing than were cells of two non-metastatic tumor lines (168 and 410). The sensitivity of all target cells was increased when endogenous prostaglandin synthesis was prevented by the addition of indomethacin (1 microM) but was not affected by the lipoxygenase inhibitor nordihydroguaiaretic acid.

Citing Articles

Targeting Lipid Peroxidation for Cancer Treatment.

Clemente S, Martinez-Costa O, Monsalve M, Samhan-Arias A Molecules. 2020; 25(21).

PMID: 33167334 PMC: 7663840. DOI: 10.3390/molecules25215144.


Antiproliferative and antiinflammatory coxib-combretastatin hybrids suppress cell cycle progression and induce apoptosis of MCF7 breast cancer cells.

Ngo Q, Thi T, Pham M, Delfino D, Do T Mol Divers. 2020; 25(4):2307-2319.

PMID: 32602075 DOI: 10.1007/s11030-020-10121-2.


Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2.

Ma X, Kundu N, Collin P, Goloubeva O, Fulton A Breast Cancer Res Treat. 2011; 132(3):1001-8.

PMID: 21761157 PMC: 3725620. DOI: 10.1007/s10549-011-1675-z.


Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function.

Kundu N, Ma X, Holt D, Goloubeva O, Ostrand-Rosenberg S, Fulton A Breast Cancer Res Treat. 2008; 117(2):235-42.

PMID: 18792778 PMC: 3738188. DOI: 10.1007/s10549-008-0180-5.


COX inhibitors and breast cancer.

Mazhar D, Ang R, Waxman J Br J Cancer. 2006; 94(3):346-50.

PMID: 16421592 PMC: 2361146. DOI: 10.1038/sj.bjc.6602942.